References
- Roth S H, Bennett R E. Nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med 1987; 147: 2093–100
- Haslock I. Review of induced upper gastrointestinal mor-bidiy and mortality. Treatment and prevention of NSAID-induced gastropathy. Royal Society of Medicine Services International Congress and Symposium Series, R Cheli. 1989; 147: 3–10
- Rainsford K D. An analysis of the gastrointestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 1982; 2: 1–10
- Soll A H, Weinstein W M, Kurata J, McCarthy D. Non steroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991; 114: 307–19
- Somerville K, Faulkner G, Langman M. Non steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 4624
- St Collier D J, Pain J A. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63
- Armstrong C P, Blower A L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: 527–32
- Larkai E N, Smith J L, Lidsky M D, Graham D Y. Gastro-duodenal mucosa and dyspeptic symptoms in arthritic patients during chronic non steroidal anti-inflammatory drug use. Am J Gastroenterology 1987; 82: 1153–8
- Jaszewski R. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or non-steroidal antiinflammatory drug therapy. J CIin Gastroenterol 1990; 12: 10–3
- Todd P A, Sorkin E M. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988; 35: 244–85
- Willkens R F. Worldwide clinical safety experience with diclofenac. Semin Arthritis Rheum 1985; 15 (Suppl 1): 105–10
- Geis G S, Stead H, Wallemark C, Nicholson P A. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. J Rheumatol 1991; 18 (suppl 28): 11–4
- Steiner J A. Misoprostol clinical pharmacology: establishment of activity in man. Dig Dis Sci 1985; 30: 136S–41S
- Dajani E Z, Nissen C H. Gastrointestinal cyto protective effects of misoprostol: clinical efficacy overview. Dig Dis Sci 1985; 30: 194s–200s
- Stromatt S C, Moreland L W, Tindall E, Brown J. Efficacy of misoprostol in the prevention of non steroidal antiinflammatory drug-induced duodenal ulcers. Hungarian Rheumatology 1991; suppl; PD4–66: 280
- Graham D Y, Agrawal N M, Roth S H. Prevention of NSAID-induced gatric ulcer with misoprostol: multi-centre, double-blind, placebo-controlled trial. Lancet 1988; 2: 1277–80
- Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31((3))315–24
- Cooperating Clinics Committee of the American Rheumatism Association. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965; 8: 302–35.
- Ward J R, Williams H J, Egger M J, et al. Comparison of auranofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1983; 26 (11): 1303–15
- Steinbrocker O, Traeger C H, Batterman R C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–62
- Ehsanullah R SB, Page M C, Tildesley G, Wood J R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297 (6655): 1017–21
- Karim A, Smith M. Pharmacokinetics of diclofenac and misoprostol when given alone or as a combination tablet. Hungarian Rheumatology 1991; suppl; P4–329: 367
- Ivey K J. Pathophysiology of NSAID-induced gastroduodenal damage: epidemiology and mechanisms of action of therapeutic agents. Aliment Pharmacol Therap 1991; 5 (suppl 1): 95–8
- Catalano M A. Worldwide safety experience with diclofenac. Am J Med 1986; 80 (suppl 4B): 81–7
- Fries J F. NSAID gastropathy: epidemiology. J Muscu-loskelMed 1991; 8: 21–8